Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women
Phase of Trial: Phase III
Latest Information Update: 04 May 2016
Price : $35 *
At a glance
- Drugs Darifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 29 Apr 2016 Status changed from recruiting to completed.
- 19 May 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.
- 19 May 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.